Getagraph.com logo
NASDAQ Composite: ( -0.01%) 16 735
S&P 500
(0.80%) 5 277.51 points
Dow Jones
(1.51%) 38 686 points
Nasdaq
(-0.01%) 16 735 points
Oil
(-0.94%) $77.18
Gas
(0.35%) $2.58
Gold
(-0.79%) $2 347.70
Silver
(-3.10%) $30.56
Platinum
(0.63%) $1 044.50
USD/EUR
(-0.17%) $0.921
USD/NOK
(-0.49%) $10.49
USD/GBP
(-0.05%) $0.785
USD/RUB
(0.15%) $90.40

Realtime updates for Eliem Therapeutics, Inc. [ELYM]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated31 May 2024 @ 16:00
25% discount on Stockinvest.us - Use code: Podcast

0.65% $ 7.71

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems...

Stats
Today's Volume 68 719.00
Average Volume 881 696
Market Cap 224.29M
EPS $-0.0614 ( 2024-05-16 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -14.83
ATR14 $0.0670 (0.88%)
Insider Trading
Date Person Action Amount type
2024-04-05 Morisset Valerie Buy 17 847 Common Stock
2024-04-05 Morisset Valerie Sell 17 847 Stock Option (Right to Buy)
2024-03-18 Pimblett Emily Buy 40 000 Restricted Stock Units
2023-09-20 Morisset Valerie Buy 15 297 Common Stock
2023-09-20 Morisset Valerie Buy 5 431 Common Stock
INSIDER POWER
38.12
Last 75 transactions
Buy: 17 601 902 | Sell: 12 020 423

Volume Correlation

Long: -0.35 (neutral)
Short: -0.92 (very strong negative)
Signal:(22.592) Possible Trading Opportunity Present (swing)

Eliem Therapeutics, Inc. Correlation

10 Most Positive Correlations
THCP0.945
AGBA0.919
IZEA0.895
NISN0.893
STCN0.89
CSTE0.886
RILY0.881
CADL0.877
RILYZ0.864
CHCI0.859
10 Most Negative Correlations
ICLK-0.946
VAXX-0.922
LINK-0.868
WVVI-0.861
APDN-0.851
SECO-0.848
MRNS-0.847
INTC-0.84
KOPN-0.834
DHCNI-0.832

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Eliem Therapeutics, Inc. Correlation - Currency/Commodity

The country flag -0.02
( neutral )
The country flag -0.23
( neutral )
The country flag 0.00
( neutral )
The country flag -0.11
( neutral )
The country flag 0.08
( neutral )
The country flag -0.10
( neutral )

Eliem Therapeutics, Inc. Financials

Annual 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-1.300
FY 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-1.300
FY 2022
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-1.720
FY 2021
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-3.05

Financial Reports:

No articles found.

Eliem Therapeutics, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Eliem Therapeutics, Inc.

Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase IIa clinical trial; and ETX-155 for the treatment of major depressive disorder, perimenopausal depression, and focal onset seizures that is in Phase I clinical trial. The company also develops preclinical pipeline programs, such as Kv7 Program for pain, epilepsy, and depression; and Anxiolytic for the treatment of generalized anxiety disorder. Eliem Therapeutics, Inc. was incorporated in 2018 and is headquartered in Redmond, Washington.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.6475081443787 seconds
Number of API calls: 2
Number of DB calls: 8